1. At a Glance – The ₹2,833 Cr Puzzle with ₹13 Cr Profit
Bhagiradha Chemicals & Industries Ltd is currently trading at ₹217 with a market cap of ₹2,833 crore. Sounds respectable, right? Now hold your calculator.
TTM sales: ₹500 crore.
TTM profit: ₹13 crore.
Stock P/E: 214.
ROCE: 5.19%.
ROE: 2.53%.
Debt: ₹189 crore.
EV/EBITDA: 64.3.
3-month return: -12%.
1-year return: -24.8%.
Let that sink in.
The company just reported Q3 FY26 sales of ₹113.97 crore with PAT of ₹4.62 crore and EPS of ₹0.36. That’s decent quarter-on-quarter growth. But the valuation? That’s Bollywood hero-level confidence.
Meanwhile, promoter holding sits at 19.6% — and has been drifting down over the years. The company is in the middle of an ₹800+ crore expansion via its subsidiary Bheema Fine Chemicals. Big ambition. Big capex. Big risk.
So the real question:
Is this a future agrochemical powerhouse in the making… or a molecule factory running ahead of its earnings?
Let’s dissect.
2. Introduction – From Lab Scientist to Leveraged Expansion
Bhagiradha Chemicals was founded in 1993 by late Sri S. Koteswara Rao, a former scientist from IICT Hyderabad. This wasn’t some “let’s trade chemicals” story. This started as hardcore chemistry.
Over time, the company built a portfolio of 32 active ingredients across insecticides, fungicides, herbicides, and specialty intermediates. It caters to 100+ domestic and 25+ multinational clients.
But here’s the twist.
For FY25:
- 97% revenue came from domestic markets.
- Only 3% from exports.
Despite exporting to USA, Brazil, Germany, UK, Israel, etc., exports form a tiny slice of revenue. Interesting.
Now comes the ambitious part.
Through wholly owned subsidiary Bheema Fine Chemicals Pvt Ltd, the company is executing an ₹800+ crore expansion program in Karnataka. The new plant has:
- 34 acres
- 9,002 MT planned capacity
- Preferential tax rate of 17.16%
Commercial production already commenced in March 2024.
Sounds like a growth story, right?
But whenever capex exceeds annual revenue by 1.6x… auditors start sharpening pencils.
Are we looking at the next specialty chemical winner — or a balance sheet stress test in progress?
3. Business Model – WTF Do They Even Do?
Bhagiradha manufactures agrochemical active ingredients.
Think:
- Chlorpyrifos
- Fipronil
- Diafenthiuron
- Azoxystrobin
- Imazethapyr
- Specialty intermediates like R-HPPA
They don’t sell shampoo bottles. They sell the molecules inside crop protection products.
They manufacture 7–10 products annually at the Ongole facility (3,250 MT capacity, ~80% utilization).
Now the Karnataka plant is expected to produce 10–14 products annually with 9,002 MT capacity.
Their strength lies in:
- 8 synthesis labs
- 60+ chemists
- Kilolab & pilot plant facilities
- 120+ reaction library
- Collaboration with partners from Japan, USA, Israel
This is not a trader. This is a process chemistry shop.
But here’s a fun thought:
If they are so R&D strong, why is ROE 2.5%?
You see, chemistry is hard. But capital allocation is harder.
4. Financials Overview – The Quarterly Reality Check
Q1 FY26 EPS: ₹0.31
Q2 FY26 EPS: ₹0.42
Q3 FY26 EPS: ₹0.36
Average = (0.31 + 0.42 + 0.36) / 3 = 0.363
Annualised EPS = 0.363 × 4 = ₹1.45 approx.
Current Price
